(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 15.69% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 56.5%.
Caredx's revenue in 2026 is $357,998,000.On average, 10 Wall Street analysts forecast CDNA's revenue for 2026 to be $21,879,958,957, with the lowest CDNA revenue forecast at $20,121,477,030, and the highest CDNA revenue forecast at $23,129,772,085. On average, 9 Wall Street analysts forecast CDNA's revenue for 2027 to be $24,159,453,517, with the lowest CDNA revenue forecast at $21,653,655,345, and the highest CDNA revenue forecast at $26,204,929,571.
In 2028, CDNA is forecast to generate $28,351,213,596 in revenue, with the lowest revenue forecast at $27,239,239,941 and the highest revenue forecast at $29,184,936,674.